Proteomic Analysis in Multiple Myeloma Research

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00051461" target="_blank" >RIV/00216224:14110/11:00051461 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/11:#0001280
Result on the web
<a href="http://dx.doi.org/10.1007/s12033-010-9326-x" target="_blank" >http://dx.doi.org/10.1007/s12033-010-9326-x</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s12033-010-9326-x" target="_blank" >10.1007/s12033-010-9326-x</a>

Result language
angličtina
Original language name
Proteomic Analysis in Multiple Myeloma Research
Original language description
Multiple myeloma (MM) is an incurable plasma cell (PC) malignancy characterized by the accumulation of monoclonal PCs in the bone marrow. For deeper understanding of the molecular mechanisms involved in the development of this disease, the influence of microenvironment, or the prediction of response of tumor PCs to anti-MM treatment, it is possible to use modern technologies for genomic and proteomic analyses. Due to progress in instrumentation, one of the main tools of proteomic analysis is mass spectrometry in combination with chosen separation techniques. This review will provide a short survey of the most commonly used proteomic techniques and show examples of their applications in MM proteome studies.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)

Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)